rs145210051

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001080414.4(CCDC88C):​c.4707G>A​(p.Arg1569Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00317 in 1,599,192 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0033 ( 13 hom. )

Consequence

CCDC88C
NM_001080414.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.668

Publications

4 publications found
Variant links:
Genes affected
CCDC88C (HGNC:19967): (coiled-coil domain containing 88C) This gene encodes a ubiquitously expressed coiled-coil domain-containing protein that interacts with the dishevelled protein and is a negative regulator of the Wnt signalling pathway. The protein encoded by this gene has a PDZ-domain binding motif in its C-terminus with which it interacts with the dishevelled protein. Dishevelled is a scaffold protein involved in the regulation of the Wnt signaling pathway. The Wnt signaling pathway plays an important role in embryonic development, tissue maintenance, and cancer progression. Mutations in this gene cause autosomal recessive, primary non-syndromic congenital hydrocephalus; a condition characterized by excessive accumulation of cerebrospinal fluid in the ventricles of the brain. [provided by RefSeq, Jan 2013]
CCDC88C Gene-Disease associations (from GenCC):
  • hydrocephalus, nonsyndromic, autosomal recessive 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • spinocerebellar ataxia type 40
    Inheritance: AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 14-91279299-C-T is Benign according to our data. Variant chr14-91279299-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 447021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.668 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00326 (4724/1446914) while in subpopulation MID AF = 0.00887 (51/5750). AF 95% confidence interval is 0.00693. There are 13 homozygotes in GnomAdExome4. There are 2253 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 13 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC88CNM_001080414.4 linkc.4707G>A p.Arg1569Arg synonymous_variant Exon 28 of 30 ENST00000389857.11 NP_001073883.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC88CENST00000389857.11 linkc.4707G>A p.Arg1569Arg synonymous_variant Exon 28 of 30 5 NM_001080414.4 ENSP00000374507.6
CCDC88CENST00000334448.5 linkn.519G>A non_coding_transcript_exon_variant Exon 4 of 6 1
CCDC88CENST00000557455.1 linkn.679G>A non_coding_transcript_exon_variant Exon 1 of 2 3
CCDC88CENST00000556726.5 linkc.*541G>A 3_prime_UTR_variant Exon 5 of 7 5 ENSP00000452406.1

Frequencies

GnomAD3 genomes
AF:
0.00225
AC:
342
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00348
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00269
AC:
608
AN:
225902
AF XY:
0.00251
show subpopulations
Gnomad AFR exome
AF:
0.000736
Gnomad AMR exome
AF:
0.00337
Gnomad ASJ exome
AF:
0.00541
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000441
Gnomad NFE exome
AF:
0.00385
Gnomad OTH exome
AF:
0.00584
GnomAD4 exome
AF:
0.00326
AC:
4724
AN:
1446914
Hom.:
13
Cov.:
30
AF XY:
0.00314
AC XY:
2253
AN XY:
718286
show subpopulations
African (AFR)
AF:
0.000720
AC:
24
AN:
33324
American (AMR)
AF:
0.00364
AC:
156
AN:
42860
Ashkenazi Jewish (ASJ)
AF:
0.00525
AC:
135
AN:
25698
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39414
South Asian (SAS)
AF:
0.000418
AC:
35
AN:
83716
European-Finnish (FIN)
AF:
0.000323
AC:
17
AN:
52578
Middle Eastern (MID)
AF:
0.00887
AC:
51
AN:
5750
European-Non Finnish (NFE)
AF:
0.00372
AC:
4103
AN:
1103736
Other (OTH)
AF:
0.00339
AC:
203
AN:
59838
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
205
410
614
819
1024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00225
AC:
342
AN:
152278
Hom.:
0
Cov.:
32
AF XY:
0.00197
AC XY:
147
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000891
AC:
37
AN:
41538
American (AMR)
AF:
0.00235
AC:
36
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00348
AC:
237
AN:
68022
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00332
Hom.:
1
Bravo
AF:
0.00245

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CCDC88C: BP4, BP7, BS2

Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Jun 07, 2017
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
7.1
DANN
Benign
0.60
PhyloP100
0.67
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145210051; hg19: chr14-91745643; COSMIC: COSV100484914; API